Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
DNA and Cell Biology|August 12, 2011
Cooperative enhancement of radiosensitivity after combined treatment of 17-(allylamino)-17-demethoxygeldanamycin and celecoxib in human lung and colon cancer cell linesYoung-Mee Kim, Hongryull Pyo
Cancer Biotherapy & Radiopharmaceuticals|December 28, 2012
Different cell cycle modulation by celecoxib at different concentrationsYoung-Mee Kim, Hongryull Pyo
American Journal of Clinical Oncology|August 7, 2003
COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancerDebabrata Saha, Hongryull Pyo, Hak Choy
Molecular Cancer Research : MCR|August 13, 2009
Cyclooxygenase-2 (COX-2) negatively regulates expression of epidermal growth factor receptor and causes resistance to gefitinib in COX-2-overexpressing cancer cellsYoung Mee Kim, Soo-Yeon Park, Hongryull Pyo
International Journal of Radiation Oncology, Biology, Physics|March 16, 2012
Celecoxib enhances the radiosensitizing effect of 7-hydroxystaurosporine (UCN-01) in human lung cancer cell linesYoung-Mee Kim, In-Hye Jeong, Hongryull Pyo
Cancers|June 19, 2024
The Prediction of Stress in Radiation Therapy: Integrating Artificial Intelligence with Biological SignalsSangwoon Jeong, Hongryull Pyo, Won Park, et al.
Molecular Cancer|August 25, 2010
Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutatedSoo-Yeon Park, Young Mee Kim, Hongryull Pyo
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 16, 2013
Hypofractionated three-dimensional conformal radiation therapy alone for centrally located cT1-3N0 non-small-cell lung cancerDongryul Oh, Yong Chan Ahn, Bokyong Kim, et al.
Molecular Cancer Therapeutics|September 20, 2005
Cyclooxygenase-independent down-regulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cellsHe-Kyung Kang, Eunmyong Lee, Hongryull Pyo, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 13, 2008
Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2Won Park, Young Taek Oh, Jae Ho Han, et al.
Pageof 9